Dr Sally Martin
Dr Martin is currently a post-doctoral researcher in the Myeloma Research Laboratory, School of Medical Sciences, University of Adelaide, based at the SAHMRI, Cancer Theme.
Dr Martin's PhD research, completed in 2009, centred on bone marrow angiogenesis and osteolytic bone disease in the haematological malignancy, multiple myeloma. Since completing her PhD studies, Dr Martin has been examining the role of the PI3K and mTOR signalling pathways in bone development, looking at ways to exploit these pathways to stimulate bone formation in disease settings such as osteoporosis and tumour-associated bone loss.
Dr Martin is an affiliate lecturer in the School of Medical Sciences and the School of Medicine, University of Adelaide.
Dr Martin's current research projects are focussed on (1) the role of the mTOR signalling pathways in mesenchymal stem cell biology, (2) the role of the mTOR signalling pathways in regulating skeletal biology and bone remodelling, and (3) the role of skeletal mTORC1 signalling in B-cell development and glucose homeostasis.
✓ Eligible to supervise Masters and PhD — email supervisor to discuss availability.
|2015||Post-doctoral Researcher||University of Adelaide, Adelaide|
|2013||Affiliate Lecturer||University of Adelaide|
|2012||Affiliate Lecturer||University of Adelaide|
|2009 - 2015||Post-doctoral Researcher||SA Pathology|
|2003 - 2008||Technical Assistant (part-time)||Institute of Medical and Veterinary Science (IMVS)|
|2005 - 2008||University of Adelaide, Adelaide||Australia||PhD|
|2000 - 2004||University of South Australia||Australia||Bachelor of Medical and Pharmaceutical Biotechnology (Hons)|
Mary Overton Early Career Research Fellowship (2012 - 2015), The role of the raptor and rictor signalling pathways in skeletal biology, AUD$252,000
Centre for Stem Cell Research Project Grant 2012, The role of raptor and rictor in MSC differentiation, AUD$75,000
Novartis Pharmaceuticals Project Grant 2011, Can the dual PI3K/mTOR inhibitor NVP-BEZ235 be used to stimulate bone formation in multiple myeloma? AUD$75,000.
|Date||Role||Research Topic||Program||Degree Type||Student Load||Student Name|
|2017||Co-Supervisor||The role of osteoblast-mTORC1 in the regulation of glucose metabolism and male fertility||Doctor of Philosophy||Doctorate||Full Time||Miss Pawanrat Tangseefa|
|2013||Co-Supervisor||Determining the Effects of Myeloma Plasma Cells on Mesenghymal Stem Cell Differentiation||Doctor of Philosophy||Doctorate||Part Time||Ms Mary Patricia Matthews|